Excellent management and home/life balance
Risky small biotech company with one "shot on goal"
Advice to Management
Keep it up; too bad about the phase 3 outcome but we all did our best. With just one more effort could have been next Genentech.
Let us know if we're missing any workplace or industry recognition –